Literature DB >> 17439835

Diffuse large B-cell lymphoma initially manifesting in the bone marrow.

Dai Kajiura1, Yoriko Yamashita, Naoyoshi Mori.   

Abstract

We histologically and immunohistochemically studied 37 cases of diffuse large B-cell lymphoma (DLBCL) initially manifesting in the bone marrow (BM). We also compared these cases with the Asian variant of intravascular large B-cell lymphoma (AIVL). Histologically, the neoplastic cells of the BM mostly had large and round nuclei and formed clusters. Immunohistochemically, all cases were positive for B-cell markers. Factor VIII staining revealed neoplastic cells within the sinusoids of BM in 8 cases; however, these cells accounted for fewer than 20% of the overall neoplastic cells. In several cases, the neoplastic cells infiltrated liver, spleen, kidneys, lungs, stomach, and adrenal glands with a mainly leukemic and infrequently intravascular pattern. Although our cases share some clinical features with AIVL, we consider DLBCL initially manifesting in the BM to be a unique entity because the neoplastic cells proliferate mainly in BM, with infrequent involvement of the sinusoids and occasional leukemic infiltration in various organs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17439835     DOI: 10.1309/2GW5W7KQBXF6LFAW

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  14 in total

1.  Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma.

Authors:  Kosei Matsue; Yoshiaki Abe; Akihiro Kitadate; Daisuke Miura; Kentaro Narita; Hiroki Kobayashi; Masami Takeuchi; Naoko Enzan; Atsushi Tanaka; Kengo Takeuchi
Journal:  Blood       Date:  2019-01-15       Impact factor: 22.113

2.  A unique bone marrow lymphoma patient presenting with an isolated mass: A case report.

Authors:  Yi-Wen Xu; Ming-Hui Duan
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

3.  Thrombocytopenia and fever: not just another infection….

Authors:  Priya Sriskandarajah; Rhys Davies
Journal:  BMJ Case Rep       Date:  2016-05-12

4.  Subtle bone marrow involvement by large B-cell lymphoma with pronormoblast-like morphology and prominent but not exclusive sinusoidal distribution.

Authors:  Christine G Roth; Kaaren K Reichard
Journal:  Am J Blood Res       Date:  2012-04-15

5.  Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.

Authors:  Pasquale Niscola; Massimiliano Palombi; Stefano Fratoni; Alessio Perrotti; Paolo de Fabritiis
Journal:  Blood Res       Date:  2013-12-24

6.  Fever and arthralgia as the initial symptoms of primary bone marrow diffuse large B-cell lymphoma: A case report.

Authors:  Saisai Ren; Yanling Tao; L U Jia; Panpan Cheng; Jilei Zhang; Hao Zhang
Journal:  Oncol Lett       Date:  2016-04-04       Impact factor: 2.967

7.  Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement.

Authors:  Byung Woog Kang; Joon Ho Moon; Yee Soo Chae; Soo Jung Lee; Jong Gwang Kim; Yeo-Kyeoung Kim; Je-Jung Lee; Deok-Hwan Yang; Hyeoung-Joon Kim; Jin Young Kim; Young Rok Do; Keon Uk Park; Hong Suk Song; Ki Young Kwon; Min Kyung Kim; Kyung Hee Lee; Myung Soo Hyun; Hun Mo Ryoo; Sung Hwa Bae; Hwak Kim; Sang Kyun Sohn
Journal:  Cancer Res Treat       Date:  2013-06-30       Impact factor: 4.679

8.  Bone marrow large B cell lymphoma bearing cyclin D3 expression: clinical, morphologic, immunophenotypic, and genotypic analyses of seven patients.

Authors:  Jyuri Watanuki; Kinta Hatakeyama; Takashi Sonoki; Hiro Tatetsu; Katsuhiko Yoshida; Soichiro Fujii; Minoru Mizutani; Toru Abo; Miwa Kurimoto; Hiroshi Matsuoka; Fumihiko Matsuno; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2009-07-29       Impact factor: 2.490

9.  Bone Marrow-Liver-Spleen Type of Large B-Cell Lymphoma Associated with Hemophagocytic Syndrome: A Rare Aggressive Extranodal Lymphoma.

Authors:  Kirill A Lyapichev; Jennifer R Chapman; Oleksii Iakymenko; Offiong F Ikpatt; Uygar Teomete; Sandra Patricia Sanchez; Francisco Vega
Journal:  Case Rep Hematol       Date:  2017-08-01

10.  Long-term remission of primary bone marrow diffuse large B-cell lymphoma treated with high-dose chemotherapy rescued by in vivo rituximab-purged autologous stem cells.

Authors:  Hiroshi Kazama; Masanao Teramura; Kentaro Yoshinaga; Akihiro Masuda; Toshiko Motoji
Journal:  Case Rep Med       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.